SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis is seeing active community discussion following its recent NYSE debut and the emergence of institutional interest in the sector. Investors are weighing the impact of upcoming legislative hearings and company-specific leadership changes against long-term growth opportunities in the U.S. medical cannabis market.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is a central point of discussion as investors debate whether recent price weakness represents a healthy consolidation or a warning sign for the broader AI-driven bull market. Community sentiment is currently polarized between those viewing this as an opportunistic rotation into oversold mega-caps and others who fear that unsustainable capital expenditure and shifting macroeconomic conditions signal a looming peak for the group.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently attracting intense community debate as investors weigh the potential of its ITK inhibitor, soquelitinib, against significant downward price pressure and high short interest. While proponents highlight ongoing institutional accumulation and a long-term 'pipeline-in-a-product' narrative, bears are focused on the lack of immediate revenue, recurring dilution, and the high-risk nature of its early-stage clinical pipeline.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum is capturing market attention as investors identify it as a potentially pivotal pure-play software provider in the quantum computing ecosystem. The stock is seeing heightened volatility and interest driven by its ultra-low float and strategic partnerships with major hardware players, leading the community to actively debate its long-term valuation relative to peers.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as the community highlights its recent v4 launch and the implementation of a revenue-sharing model for node runners and stakers. Investors are focused on the project's significant supply scarcity, with a large majority of the float currently locked in long-term staking pools.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is generating significant community interest as investors weigh its strong fundamentals, operational efficiency, and potential acquisition activity against the broader volatility in global oil markets. Traders are actively discussing the company's prospects in light of Middle Eastern supply concerns, focusing on how its low break-even costs and potential for increased takeaway capacity could drive long-term value despite short-term fluctuations.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending as investors aggressively position themselves ahead of upcoming quarterly earnings and the highly anticipated Cerebras Systems IPO, viewing the stock as a strategic proxy for AI compute demand. Community sentiment is driven by the companys recent infrastructure contracts and its role in the AI data center buildout, though discussions also reflect high volatility and skepticism regarding leadership and execution.

Allora is a decentralized intelligence network that makes artificial intelligence more adaptive, collaborative, and efficient. The platform combines and coordinates thousands of specialized AI models in real time to produce superior inferences for users and applications. By enabling anyone to contribute models, data, or validation, Allora creates a self-improving market for intelligence that powers agents, DeFi systems, and AI applications across chains.

Allora

Allora is capturing community attention due to its decentralized machine intelligence technology, with supporters highlighting recent developments and integration potential while monitoring technical indicators for signs of a sustained breakout. While some participants express optimism over its utility and potential for price appreciation, others are debating whether current price action represents a genuine trend or speculative volatility.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is currently sparking intense debate within the crypto community, with some investors dismissing the project as a scam while others remain optimistic, viewing recent price movements as a potential setup for a significant rally. Discussions are heavily focused on speculative 10x-to-50x growth targets, debates over potential ETF applications, and broader market sentiment regarding meme coins and upcoming crypto-friendly political developments.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending as investors react to a wave of bullish analyst initiations that cite the company's wafer-scale chip technology as a strong challenger in the AI inference market. While some community members are optimistic about its potential to disrupt incumbents, others remain cautious, pointing to concerns over lock-up expirations, valuation multiples, and the competitive dominance of established GPU architectures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Emerging Growth Stocks Enter Breakout Territory

A wave of high-impact developments is drawing investor attention as multiple emerging growth companies advance toward potentially transformative milestones. $CRVO, $NTHI, $CAST, $LNKS, $BFLY, $QS, $APWC

Brains, AI Imaging, and Breakthrough Antibiotics Ignite Investor Buzz

The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand commercialization efforts. Recent developments from CervoMed (NASDAQ:CRVO), Butterfly Network (NYSE:BFLY), NeOnc (NASDAQ:NTHI), Spero Therapeutics (NASDAQ:SPRO), GSK (NYSE:GSK), and IceCure Medical (NASDAQ:ICCM) highlight several emerging themes shaping the sector, including neurodegenerative disease treatment, AI-powered diagnostics, antimicrobial resistance, minimally invasive cancer care, and synthetic biology.

Technological Innovations to Wage War Against Some of Medicine's Toughest Diseases

The biotechnology space is delivering a steady stream of potentially market-moving developments this week as companies across oncology, neuroscience, gene therapy, medical devices, and synthetic biology delivered significant regulatory, clinical, and commercial updates. $NTHI, $QURE, $ICCM, $CLPT, $ELTX, $AZTR

Power Hour Breakouts: Clinical Catalysts and New Highs Send Traders Hunting for the Next Winner

Clinical milestones, regulatory progress, insider buying, and newly public biotechnology platforms are among the leading themes for today’s power hour. $CRVO, $NTHI, $SLBT, $SPCX, $WULF, $AMAT, $EW, $OSCR

Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum

Multiple clinical-stage companies are delivered meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events. $NTHI, $SLBT, $CRVO, $EWTX

Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND

NeOnc Technologies Holdings (NASDAQ:NTHI) continues to build momentum as a neuro-oncology sector trailblazer, as it advances multiple clinical programs targeting some of the most difficult cancers to treat, after announcing that the Department of Health – Abu Dhabi granted Investigational New Drug (IND) authorization for NEO212, the company's oral perillyl alcohol-temozolomide conjugate being developed for aggressive brain tumors. The approval represents the first international regulatory clearance for NEO212 following completion of the Phase 1 dose-escalation study, which established 610 mg as the recommended Phase 2 dose. The authorization creates an additional clinical development pathway outside the United States as the company continues discussions with the U.S. Food and Drug Administration regarding a potential registrational strategy.

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

Others

Why Traders Are Piling into These Emerging Healthcare Names as New Catalysts Emerge

Biotechnology and healthcare innovation dominated investor conversations today as multiple companies delivered meaningful corporate, clinical, regulatory, and commercialization updates. From artificial intelligence-powered drug discovery platforms to neuro-oncology, regenerative medicine, wound care technologies, and autoimmune disease therapies, investors focused on companies that could potentially benefit from major industry trends while advancing important milestones of their own. $CUPR, $HYFT, $NTHI, $RGNT, $GELS, $SABS

These Are the Stocks Traders Are Watching into the Close

As the market enters the final stretch of trading, one story is dominating virtually every trading desk on Wall Street: the historic debut of SpaceX. The company's long-awaited public offering has generated extraordinary volume, massive investor interest, and renewed enthusiasm across multiple high-growth sectors including space infrastructure, artificial intelligence, biotechnology, and advanced communications. $NTHI, $SPCX, $ELVN, $POET, $RNAC, $ALOY

Volume Explosion has Traders Swarming into These 6 Stocks

Volume often tells investors where attention is flowing before the broader market fully recognizes a developing story. While each story is very different, all share one common trait: investors are watching closely for what comes next. $NOK, $NTHI, $AKAN, $DSY, $ASTS, $RKLB

This account has been verified as an official NTHI representative.

Verified Account

NeOnc Technologies

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

NeOnc Technologies Holdings Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

NTHINeOnc Technologies Holdings Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NTHI News